Fig. 4From: Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathwaysActivation of YAP/TAZ and EGFR/HER2 signaling pathways in human liver cancers. Microscopic images showing IHC staining for YAP, TAZ, pEGFR, and phosphorylated downstream effector molecules of EGFR/HER2 in human HCC and CC. Scale bar, 50 μmBack to article page